Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (261-270 of 299) with videos related to

Pageof 30
Sort By:
British Journal of Haematology|September 4, 2010
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21Marta Scandurra, Michael Mian, Timothy C Greiner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphomaTimothy S Fenske, Parameswaran N Hari, Jeanette Carreras, et al.
Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomasAndrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Blood|December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaJaveed Iqbal, Yulei Shen, Xin Huang, et al.
Science Translational Medicine|June 21, 2019
Targetable genetic alterations of <i>TCF4</i> (<i>E2-2</i>) drive immunoglobulin expression in diffuse large B cell lymphomaNeeraj Jain, Keenan Hartert, Saber Tadros, et al.
Blood|June 19, 2008
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative studyKen H Young, Karen Leroy, Michael B Møller, et al.
British Journal of Haematology|July 9, 2013
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementRichard T Maziarz, Zhiwei Wang, Mei-Jie Zhang, et al.
Blood Advances|January 17, 2020
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogeneticsPallawi Torka, Shalin K Kothari, Suchitra Sundaram, et al.
Blood Advances|January 16, 2026
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN StudyKrish Patel, Julie M Vose, Sunita D Nasta, et al.
Pageof 30

Showing results (261-270 of 299) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|September 4, 2010
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21Marta Scandurra, Michael Mian, Timothy C Greiner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphomaTimothy S Fenske, Parameswaran N Hari, Jeanette Carreras, et al.
Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomasAndrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Blood|December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaJaveed Iqbal, Yulei Shen, Xin Huang, et al.
Science Translational Medicine|June 21, 2019
Targetable genetic alterations of <i>TCF4</i> (<i>E2-2</i>) drive immunoglobulin expression in diffuse large B cell lymphomaNeeraj Jain, Keenan Hartert, Saber Tadros, et al.
Blood|June 19, 2008
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative studyKen H Young, Karen Leroy, Michael B Møller, et al.
British Journal of Haematology|July 9, 2013
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementRichard T Maziarz, Zhiwei Wang, Mei-Jie Zhang, et al.
Blood Advances|January 17, 2020
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogeneticsPallawi Torka, Shalin K Kothari, Suchitra Sundaram, et al.
Blood Advances|January 16, 2026
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN StudyKrish Patel, Julie M Vose, Sunita D Nasta, et al.
Pageof 30